Pay in 4 interest-free payments of $81.25 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
marketed for therapeutic use as Intron-A®
C20H16D5N5O6 / 432
58 / A peracetylated β-D-N-acetylgalactosamine (GalNAcβ) ligand equipped with an amine-functionalized linker through a pentyl spacer
/ β-GlcNAc-PEG3-Azide / β-GlcNAc-PEG3-N3
1-Dimethylethyl-d9)-3-oxo-4-azaandrost-1-ene-17-carboxamide
SI230011: 8-Hydroxy Warfarin-d5 label-new marketed for therapeutic use asC19H11D5O5 329. 36 CYP1A2 Metabolite of Warfarin 8 Hydroxy Warfarin d5 4,8 Dihydroxy 3 [3 oxo 1 (phenyl d5) butyl] 2H 1 benzopyran 2 one; 3 ( Acetonylbenzyl) 4,8 dihydroxycoumarin d5
US$ 78.65
US$ 78.65
US$ 78.65
US$ 44.00
US$ 132.50
US$ 78.65
US$ 130.00
